Trial Profile
Clinical Trials Insight: 700048795
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 15 Sep 2009
Price :
$35
*
At a glance
- Drugs Ruxolitinib (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors Incyte Corporation
- 15 Sep 2009 New trial record.